Hindustan Unilever Limited
Quality (81/100) does the heavy lifting; valuation (4/100) is the drag.
ExpensiveOvervaluedHindustan Unilever Limited earns a Sell from StocksWizard, with a blended score of 41/100. We put fair value near ₹1,050.65; at ₹2,101.3 that leaves roughly 50% downside, so the stock screens overvalued by 50%. On 47.8x trailing earnings it sits pricier than the Consumer Defensive median of about 26.1x. The price is about 21% below its 52-week high of ₹2,644.7 and 4% above the low of ₹2,022.7. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹2,557.73 implies about 22% upside across 37 analysts. It clears 6 of 13 investability checks, with durability 81, valuation 8 and momentum 21 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹840.52.
Analyst views
1-year price
EOD · 2026-07-3152-week range
-20.55% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell41Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 21.6%
- Pass: Low debt (D/E < 0.5): 0.03x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 4%
- Pass: Earnings growing: 21%
- Pass: Net margin ≥ 10%: 23.3%
- Fail: Current ratio > 1.5: 1.22
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Pass: Altman Z in safe zone: Z 10.86
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter62.3%
- Institutions20.9%
- Public & other16.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (21.6%).
- Lightly leveraged balance sheet.
- Healthy profit margin (23.3%).
- Financially solid — Altman Z 10.86.
Opportunities
- Earnings growing (21% YoY).
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Threats
- Rich valuation versus sector peers.
- Trades ~50% above our estimated fair value.
About Hindustan Unilever Limited
Hindustan Unilever Limited manufactures and distributes fast-moving consumer goods across India and international markets through five operating segments: Home Care, Beauty & Wellbeing, Personal Care, Foods, and Others. Its product portfolio includes detergent bars, powders, and liquids; scourers; skin and hair care products; skin cleansing, oral care, body wash, and deodorants; and culinary products including tomato-based items.
Hindustan Unilever Limited — frequently asked questions
Is Hindustan Unilever Limited a buy, hold or sell?
StocksWizard currently rates Hindustan Unilever Limited (HINDUNILVR) a Sell, based on a blended score of 41/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Hindustan Unilever Limited's fair value?
Our blended DCF and relative-valuation model estimates Hindustan Unilever Limited's fair value at about ₹1,050.65, versus a current price of ₹2,101.3 — roughly 50% downside. On that basis the stock looks overvalued by 50%.
Is Hindustan Unilever Limited financially healthy?
Hindustan Unilever Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Hindustan Unilever Limited's share price performed?
Hindustan Unilever Limited is down 9% over three months, and last traded at ₹2,101.3. Past performance doesn't predict future returns.
More in Consumer Defensive
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.